81 completed, 18 recruiting, 17 unknown, 10 active not recruiting. 141 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 141 | Completed 81, Recruiting 18, Unknown 17, Active not recruiting 10, Not yet recruiting 5, Terminated 5, Withdrawn 3, Enrolling by invitation 2 |
Follow AstraZeneca: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Optimizing Care For Management Of Hard To Control Hypertension In Low-Income Patients Across Family Health Centers In New York City Multilevel Hypertension Care Model - Hypertension | Not applicable | Not yet recruiting | NYU Langone Health | 628 | 2027-02-01 | 2026-07-14 |
| A Restorative Justice-Based Lung Cancer Screening Decision-Making Support Intervention Tailored for Black Individuals to Increase Lung Cancer Screening Among Black Community Members, RESTORE Trial Educational Intervention, Survey Administration, Interview - Lung Carcinoma | Not applicable | Recruiting | Fred Hutchinson Cancer Center | 45 | 2026-12-01 | 2026-10-29 |
| Impact of Multidisciplinary Care, Structured and Targeted on the COPD Patient's Clinical Pathway. COPD targeted pharmaceutical interview and consultation, Respiratory Insufficiency Day Hospitalization, Pulmonary Function Test - Chronic Obstructive Pulmonary Disease, Lung Diseases, Obstructive | Not applicable | Not yet recruiting | Centre Hospitalier Universitaire de Nīmes | 116 | 2026-11-01 | 2026-10-30 |
| Advanced Robotic Techniques and Rapid Onsite Evaluation for Minimally Invasive Diagnosis and Next-Generation Sequencing. Rapid onsite evaluation - Peripheral Pulmonary Lesions (PPLs) | Not applicable | Not yet recruiting | Vanderbilt University Medical Center | 400 | 2026-10-01 | 2026-07-06 |
| Effectiveness of Chat-based Mobile Application for Consultation (Zalo) in Improving Compliance With Follow-up Tests After Abnormal Chest X-ray Findings Interpret by Artificial Intelligent chat-based mobile application (Zalo) - Lung Cancer, Tuberculosis (TB) | Not applicable | Recruiting | Gia Dinh People Hospital | 2692 | 2026-09-15 | 2026-09-16 |
| Baxdrostat and Molecular Imaging of Adrenal Cytoreduction in Primary Aldosteronism baxdrostat - Primary Aldosteronism | Not applicable | Not yet recruiting | Queen Mary University of London | 30 | 2026-09-15 | 2026-09-02 |
| Impact of GDMT in Uncontrolled Asthma Patients Receiving MHD Inhaled Corticosteroids + Long-acting β2 Agonist Intervention group - Uncontrolled Asthma | Not applicable | Recruiting | AstraZeneca | 540 | 2026-09-05 | 2026-09-24 |
| COPD Flare-Up Clinic After Severe Exacerbations Follow-up in a flare-up clinic - COPD, COPD Exacerbation (AECOPD) | Not applicable | Recruiting | Tel-Aviv Sourasky Medical Center | 240 | 2026-07-01 | 2026-09-24 |
| AI-based Echocardiography for Detection of Cardiac Amyloidosis AI-based echocardiogram - Cardiac Amyloidosis, Heart Failure With Preserved Ejection Fraction (HFPEF) | Not applicable | Not yet recruiting | Germans Trias i Pujol Hospital | 200 | 2026-07-01 | 2026-06-12 |
| Explore the Diagnostic Value of Bronchodilation Test With Portable Oscillometry in Asthma Diagnosis Pulmonary function Test intervention - Suspected Asthma | Not applicable | Recruiting | AstraZeneca | 500 | 2026-06-10 | 2026-10-13 |
| A Study of MET Concordance and Gene Profiling in 1L NSCLC (Genomet) NGS testing, MET IHC testing, PD-L1 and Her2 testing - Non-Small Cell Lung Cancer | Not applicable | Recruiting | AstraZeneca | 1000 | 2026-06-02 | 2026-10-26 |
| Implementation of Standardized Early Identification and Diagnosis for Transthyretin Amyloidosis (ATTR) in High-Risk Populations implementation of standard early identification and diagnosis of ATTR - ATTR-CM | Not applicable | Active not recruiting | AstraZeneca | 4000 | 2026-04-21 | 2026-08-07 |
| Structured Review: To Optimise Management and Prevent Harm in COPD Sputum sample, Venepuncture, Lung function test - COPD | Not applicable | Recruiting | Northumbria Healthcare NHS Foundation Trust | 96 | 2026-03-11 | 2026-04-23 |
| Enhanced COPD Management in Suspected Lung Cancer Patients Tailored COPD consultations - COPD (Chronic Obstructive Pulmonary Disease), Lung Cancer (Diagnosis) | Not applicable | Recruiting | Ditte Krag-Hansen | 280 | 2026-03-06 | 2026-04-22 |
| Study of Palivizumab in Children With High Risk of Severe Respiratory Syncytial Virus (RSV) Disease Palivizumab 15 mg/kg - Respiratory Syncytial Virus (RSV) | Not applicable | Active not recruiting | AstraZeneca | 21 | 2025-12-10 | 2026-09-09 |
| The Prevalence of COPD in Patients With Cardiovascular Disease and the Benefit of Cardiopulmonary Co-management Guideline education and implementation intervention - Cardiovascular Diseases | Not applicable | Recruiting | AstraZeneca | 3000 | 2025-11-28 | 2026-09-01 |
| Addressing Unfunded Vaccines Through a Co-payment Mechanism in Pharmacies Co-payment Model - Step 1, Co-payment Model - Step 2, Co-payment Model - Step 3 - Preventable Disease, Vaccine | Not applicable | Recruiting | Canadian Immunization Research Network | 600 | 2025-10-23 | 2026-03-19 |
| Determining Efficacy of an Artificial Intelligence-based System for Heart Failure Detection Through Interpretation of Electrocardiograms (DECISION) Willem™ platform ECG assessment - Heart Failure, Cardiovascular Risk Factors | Not applicable | Recruiting | Idoven 1903 S.L. | 1968 | 2025-07-23 | 2026-07-20 |
| Hyperkalemia Quality Improvement Program (HK-QIP) Study standard hyperkalemia management implementation - Hyperkalemia | Not applicable | Active not recruiting | AstraZeneca | 1000 | 2025-06-25 | 2026-08-20 |
| Identification of Innovative Biomarkers to Predict Outcomes in Hepatocellular Carcinoma Treated With Tremelimumab and Durvalumab blood sample - Hepatocellular Carcinoma | Not applicable | Recruiting | Centre Hospitalier Universitaire de Besancon | 120 | 2025-06-25 | 2026-07-23 |
Showing 20 of 141. Sign in to see all of them.
Asthma (14) · Pulmonary Disease, Chronic Obstructive (12) · Breast Neoplasms (9) · Heart Failure (9) · Cardiovascular Diseases (8) · Carcinoma, Non-Small-Cell Lung (7) · Diabetes Mellitus, Type 2 (7) · Lung Neoplasms (7) · Acute Coronary Syndrome (3) · Disease (3) · Hypertension (3) · Leukemia, Lymphocytic, Chronic, B-Cell (3) · Neoplasm Metastasis (3) · Ovarian Neoplasms (3) · Patient Compliance (3)
Budesonide (6) · Quetiapine Fumarate (5) · dapagliflozin (5) · Esomeprazole (4) · Patient Reported Outcome Measures (3) · Ticagrelor (3) · Anastrozole (2) · Blood Specimen Collection (2) · Budesonide, Formoterol Fumarate Drug Combination (2) · Cognitive Behavioral Therapy (2) · Early Intervention, Educational (2) · Educational Status (2) · Electrocardiography (2) · Gefitinib (2) · Inhalation (2)
United States (46) · United Kingdom (15) · China (14) · France (10) · Canada (9) · Sweden (8) · Netherlands (6) · South Korea (6) · Spain (6) · Denmark (5) · Germany (5) · India (3) · Israel (3) · Taiwan (3) · Thailand (3)
Mark C Petrie, MbChB (2) · Ralph A DeFronzo, MD (2) · A Lopez-Santiago, MD (1) · A Lopez-santiago, MD (1) · Ala' I. Sharara, MD (1) · Alan Ho, MD, PhD (1) · Alberto Cukier, M/D (1) · Alejandro Mohar (1) · Alexi A Wright, MD, MPH (1) · Alice Turner, MD (1) · Amelia Siu (1) · Amit Oza, M.D. (1) · Andre M Tapp, MD (1)
PMID 17258973, PMID 18561930, PMID 19474425, PMID 20048218, PMID 20184807, PMID 20598302, PMID 20701823, PMID 20857372, PMID 20871122, PMID 20950306, PMID 21679712, PMID 21903370, PMID 22561055, PMID 23102518, PMID 23406027, PMID 23891588, PMID 24024838, PMID 24232701, PMID 24341382, PMID 24669750, PMID 24735128, PMID 26117466, PMID 26487563, PMID 26901812, PMID 27730116, PMID 27852260, PMID 28684597, PMID 28960335, PMID 29340498, PMID 29401239, PMID 29844102, PMID 30101278, PMID 30420252, PMID 30629160, PMID 30689105, PMID 30898204, PMID 31554423, PMID 31738483, PMID 31984235, PMID 32028138, PMID 32067695, PMID 32078484, PMID 32375735, PMID 32444417, PMID 32480409, PMID 32594766, PMID 32694214, PMID 33347326, PMID 33789635, PMID 33980690
2018 (1), 2025 (1), R01AG030545 (1), R01DK024092 (1), R21AT004024 (1)